尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Hyllengren Eric J. Director active across 1 company, notably Atara Biotherapeutics, Inc.. In total, 11 filings have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €72k. History available since 16 May 2023. The latest transaction was filed on 3 March 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Hyllengren Eric J is a declarant linked to Atara Biotherapeutics, Inc. (XNAS), where the listed role is EVP, CFO and COO. He has 11 filings in total, and the recent filings observed between 2023-05-18 and 2025-03-05 show only sales, for a total of EUR 71979.